CAMP Camp4 Therapeutics
- 4.500
- -0.450-9.09%
- 4.510
- +0.010+0.22%
Camp4 Therapeutics所有資訊
Camp4 Therapeutics | 10-Q：季度報表
Camp4 Therapeutics | 8-K：CAMP4 公佈 2024 年第三季度財務業績
Camp4 Therapeutics | SC 13G：超過5%持股股東披露文件-Michael P. Rubin(11.5%),Northpond Ventures II, LP(5.1%)等
Camp4 Therapeutics | SC 13D：超過5%持股股東披露文件-Amir Nashat(13.5%),Polaris Management Co. VII, L.L.C.(8.8%)等
Camp4 Therapeutics | 4/A：持股變動聲明(修正)-股東 Polaris Management Co. VII, L.L.C.
Camp4 Therapeutics | 3/A：首次持股聲明(修正)-股東 Polaris Partners GP X, L.L.C.
Camp4 Therapeutics | SC 13G：超過5%持股股東披露文件-Marc Andreessen(10.9%),Benjamin Horowitz(10.9%)等
Camp4 Therapeutics | SC 13D：超過5%持股股東披露文件-Enavate Sciences GP, LLC(19.4%),Everest Aggregator, LP(19.4%)
Camp4 Therapeutics | SC 13D：超過5%持股股東披露文件-Andrew J. Schwab(15.0%),Dr. Kush Parmar(15.0%)等
Camp4 Therapeutics | 4：持股變動聲明-股東 Northpond Ventures II GP, LLC
Camp4 Therapeutics | 4：持股變動聲明-股東 AH Equity Partners Bio I, L.L.C.
Camp4 Therapeutics | 4：持股變動聲明-股東 Enavate Sciences GP, LLC
Camp4 Therapeutics | S-8：員工福利計劃證券登記
Camp4 Therapeutics | SEC STAFF LETTER：其他
Camp4 Therapeutics | 4：持股變動聲明-股東 Polaris Management Co. VII, L.L.C.
Camp4 Therapeutics | 4：持股變動聲明-股東 5AM Partners VI, LLC
Camp4 Therapeutics | 4：持股變動聲明-董事 Schwab Andrew J.
Camp4 Therapeutics | 4：持股變動聲明-董事 Nashat Amir
Camp4 Therapeutics | 4：持股變動聲明-董事 Holtzman Steven H
Camp4 Therapeutics | 4：持股變動聲明-董事 Young Richard A
暫無數據
